
Cefutri S Duo 1000mg/500mg Injection
Marketer
Associated Biopharma
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Cefutri S Duo 1000mg/500mg Injection
Cefutri S Duo 1000mg/500mg injection, a dual-action antibiotic, combats diverse bacterial infections by hindering microbial proliferation. Administered solely by a healthcare provider, this medication necessitates adherence to the prescribed schedule. Complete the full course of treatment, even with symptom improvement, as premature cessation may compromise its efficacy. Potential side effects, including nausea, vomiting, diarrhea, and digestive upset, may occur. Severe side effects warrant immediate medical attention. Allergic reactions (skin rashes, itching, swelling, respiratory distress) require prompt emergency care. Inform your physician of all current medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving, drowsiness or dizziness necessitates driving cessation. Adequate rest, proper nutrition, and ample hydration facilitate recovery. Monitoring via laboratory tests may be employed to assess treatment efficacy.
Primary Ingredients of Cefutri S Duo 1000mg/500mg Injection
No text provided to rephrase.
Uses of Cefutri S Duo 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Cefutri S Duo 1000mg/500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Cefutri S Duo 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefutri S Duo 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Cefutri S Duo 1000mg/500mg Injection works:
Ceftriaxone and Sulbactam, combined as Cefutri S Duo 1000mg/500mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a potent antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to reproduce. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thus boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from co-administering Cefutri S Duo 1000mg/500mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
Cefutri S Duo 1000mg/500mg injections are typically deemed safe for pregnant individuals. Preclinical trials using animals revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
The administration of Cefutri S Duo 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily suspended throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The combination injection Cefutri S Duo (1000mg/500mg) can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Cefutri S Duo 1000mg/500mg Injection to individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCAUTION
The injectable combination Cefutri S Duo (1000mg/500mg) requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alterations for Cefutri S Duo (1000mg/500mg) injection are not advised for those with mild or moderate liver dysfunction.
What if you forget to take Cefutri S Duo 1000mg/500mg Injection :
Omitting a scheduled dose of Cefutri S Duo 1000mg/500mg Injection necessitates contacting your physician.
Facts to Know About Cefutri S Duo 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
